Clarivate股票討論區

$Clarivate(CLVT.US)$ beginning of new round of squeeze  in game 📈 lets go !

Pre-Market Stock Movers
Gapping up
$Adobe(ADBE.US)$ stock rose 1.6% after Mizuho Securities upgraded the computer software company to ‘buy’ from ‘neutral’, saying it is well-positioned to capitalize on digital transformation with its highly comprehensive end-to-end offering.
$DocuSign(DOCU.US)$ stock rose 1% after the e-signature company beat expectations in its second quarter, with revenue up 10.5% year-on-year, and thu...

Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $高樂氏(CLX.US)$ - up 4.6%
2. $高知特(CTSH.US)$ - up 4.1%
3. $Informatica(INFA.US)$ - up 2.8%
4. $BOSS直聘(BZ.US)$ - up 2.7%
5. $Sunrun(RUN.US)$ - up 2.6%
6. $再生元製藥公司(REGN.US)$ - up 1.9%
7. $麥克森(MCK.US)$ - up 1.9%
8. $寇蒂斯萊特(CW.US)$ - up 1.7%
9. $MercadoLibre(MELI.US)$ - up 1.5...

$Clarivate(CLVT.US)$2018年上市以來營收快速增長5年，營業利潤也由虧損轉爲盈利，但是淨利潤受高昂的利息費用影響持續虧損，2022年還有44.5億的資本性資產減值，應該是前幾年收購的惡果開始出現了，暫時沒有投資價值。

Here are the top gap ups and downs for the stocks with a market cap above $5 billion after the previous market closed (gaps range from large to small):
Gap Ups
1. $Sarepta Therapeutics(SRPT.US)$ - up 16.8%
2. $Clarivate(CLVT.US)$ - up 4.8%
3. $第一太陽能(FSLR.US)$ - up 4.4%
4. $網易(NTES.US)$ - up 3.8%
5. $滿幫(YMM.US)$ - up 3.7%
6. $華住(HTHT.US)$ - up 3.0%
7. $BOSS直聘(BZ.US)$ - up 2.8%
8. $新東方(EDU.US)$ - up 2.7%...

Gainers:
In reaction to earnings/guidance:
• $GoodRx(GDRX.US)$ +38.5%, $EDGIO(EGIO.US)$ +13.5%, $Lemonade(LMND.US)$ +10.7%, $Desktop Metal(DM.US)$ +8.5%, $ShockWave Medical(SWAV.US)$ +8.2%, $Pubmatic(PUBM.US)$ +8.1%, $Olaplex(OLPX.US)$ +7%, $Vivid Seats(SEAT.US)$ +6.4%, $Noble(NE.US)$ +6.3%, $艾斯本科技(AZPN.US)$ +5.4%, $艾倫建材(AAON.US)$ +5%, $Hudbay Minerals(HBM.US)$ +5%, $Vivint Smart Home(VVNT.US)$ +4.9%, $Vivint Smart Home(VVNT.US)$ +4...

Gainers:
• $Canoo(GOEV.US)$ +71.3% (receives purchase order of 4500 Canoo Electric Delivery Vehicles from Walmart)
• $Aldeyra Therapeutics(ALDX.US)$ +14.1% (achieved primary endpoints in dry eye disease chamber crossover clinical trial)
• $西港燃料(WPRT.US)$ +10.9% (awarded 38 mln program)
• $Greenwich LifeSciences(GLSI.US)$ +5.9% (FDA has removed the clinical hold permitting the Flamingo-01 Phase III clinical trial to proceed...